Goldman Sachs Group Inc. reduced its stake in Markel Co. (NYSE:MKL) by 8.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 52,188 shares of the insurance provider’s stock after selling 4,560 shares during the period. Goldman Sachs Group Inc. owned approximately 0.38% of Markel worth $59,449,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds also recently added to or reduced their stakes in MKL. Aevitas Wealth Management Inc. bought a new stake in shares of Markel in the 4th quarter valued at approximately $108,000. First Personal Financial Services grew its stake in shares of Markel by 156.1% in the 4th quarter. First Personal Financial Services now owns 105 shares of the insurance provider’s stock valued at $120,000 after purchasing an additional 64 shares during the period. SeaCrest Wealth Management LLC bought a new stake in shares of Markel in the 4th quarter valued at approximately $122,000. Simplex Trading LLC grew its stake in shares of Markel by 169.1% in the 4th quarter. Simplex Trading LLC now owns 148 shares of the insurance provider’s stock valued at $168,000 after purchasing an additional 93 shares during the period. Finally, Cigna Investments Inc. New bought a new stake in shares of Markel in the 4th quarter valued at approximately $201,000. Institutional investors own 78.13% of the company’s stock.
Several equities research analysts have recently weighed in on MKL shares. Zacks Investment Research upgraded Markel from a “hold” rating to a “buy” rating and set a $1,253.00 price objective on the stock in a research note on Friday, January 5th. SunTrust Banks upped their price objective on Markel to $1,200.00 and gave the company a “hold” rating in a research note on Thursday, February 8th. Royal Bank of Canada reiterated a “hold” rating and issued a $1,200.00 price objective on shares of Markel in a research note on Thursday, February 8th. Finally, ValuEngine lowered Markel from a “hold” rating to a “sell” rating in a research note on Thursday, March 1st. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the stock. Markel currently has an average rating of “Hold” and an average target price of $1,172.00.
Shares of Markel Co. (MKL) opened at $1,159.31 on Friday. The company has a market capitalization of $16,115.57, a P/E ratio of 1,998.81 and a beta of 0.95. Markel Co. has a 12-month low of $936.95 and a 12-month high of $1,164.70. The company has a current ratio of 0.60, a quick ratio of 0.60 and a debt-to-equity ratio of 0.33.
Markel (NYSE:MKL) last released its quarterly earnings results on Tuesday, February 6th. The insurance provider reported $6.64 EPS for the quarter, missing the Zacks’ consensus estimate of $8.55 by ($1.91). The business had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.58 billion. Markel had a return on equity of 0.39% and a net margin of 6.52%. analysts anticipate that Markel Co. will post 33.19 earnings per share for the current year.
Markel Corporation is a financial holding company serving a range of markets. The Company’s principal business markets and underwrites specialty insurance products. It monitors and reports its ongoing underwriting operations in three segments: U.S. Insurance, International Insurance and Reinsurance. The Company, through its subsidiary Markel Ventures, Inc (Markel Ventures), owns interests in various industrial and service businesses that operate outside of the specialty insurance marketplace.
Receive News & Ratings for Markel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel and related companies with MarketBeat.com's FREE daily email newsletter.